Skip to main content

Accord Healthcare Backs Medicines for Europe’s Bid for Wider EU Medicine Access

By Ian Weatherhead- Senior Director, Public Affairs, EMENA

As the EU institutions deliberate on the reform of the critical EU pharmaceutical legislation, focused on the ‘access’, ‘affordability’ and ‘availability’ of medicines across the Union, Accord Healthcare is pleased to support Medicines for Europe through the endorsement of its election manifesto, focused on the ‘levelling up’ of the European health union.

With the EU’s general pharmaceutical legislation not having been revised since 2004, the policy decisions that the EU will validate over the coming months and fully implement during its next mandate (from July this year) will shape national health systems and influence the health and well-being of millions of citizens across Europe.

We joined off-patent industry colleagues in Brussels to lend our support to this new agenda and the priorities set out in Medicines for Europe’s manifesto, to ‘leave no patient behind’. The off-patent industry provides close to 70% of the medicines dispensed in Europe, and therefore plays a central role in providing patients access to treatments, through the 27 member states and beyond.

Accord Healthcare employs around 2,000 colleagues across the EMENA region and with a presence in all 27 member states. The company has over 9,000 medicines marketed across Europe, with over 40 oncology and oncology-related treatments across its portfolio.

In addition, we have a significant manufacturing footprint in Europe, so we instinctively echo the call of Medicines for Europe for greater investment in off-patent medicines manufacture, to make it more competitive, more sustainable, and more digitally-enabled; in turn contributing to stronger health resilience across the continent.

The full Medicines for Europe election manifesto can be found here, but can be summarised as follows:

Reform of EU pharmaceutical laws for equitable access, by fostering timely competition and sustainable uptake of generic, biosimilar and value-added medicines.

Drive competition in pharma markets to increase access and sustain healthcare budgets.

Invest in affordable off-patent innovation to solve healthcare and patient challenges.

Improve supply chain security and reduce shortage risks.

Provide transparency on temporary disruption of supply.

Support pro-competitive measures in the pharma and intellectual property legislations, especially to stop delays to generic and biosimilar entry.

Facilitate earlier entry of generics and biosimilars to increase competition and availability in all Member States.

Create a framework for value added medicines development.

Tackle the economic root causes of medicine shortages and facilitate a solidarity-based allocation of medicines across the EU to solve shortages.

Reform tender policies with EU guidance on medicine procurement.

In the pursuit of a more accessible and sustainable healthcare system across Europe, Accord Healthcare stands committed to supporting Medicines for Europe’s vision for the “levelling-up” of the European health union. With our extensive presence, diverse portfolio, and manufacturing footprint, we are dedicated to advancing access, affordability, and sustainability in healthcare, ensuring “no patient is left behind”.

General (the “Site") is owned and operated by Accord Healthcare, Ltd. (“Accord”), a company registered in England and Wales, with company number 04596349 and with registered office at Sage House, 319 Pinner Road, North Harrow, Middlesex, HA1 4HF, United Kingdom. Accord’s VAT number is GB 894350693.

Terms of Use
By accessing the Site or by otherwise accessing any content found on this Site, you agree to be bound by the following terms and conditions (“T&C”).

Contents of this Site
All the information and contents of the Site (including, but not limited to, its graphics, logos, designs, images and source codes used for programming) are the property of Accord or its licensors, as the case may be.

You may not use or reproduce or allow anyone to use or reproduce any “Accord” names and logos, and any other graphics or trademarks (whether registered or unregistered) appearing on the Site for any reason without written permission from Accord.

The software that operates the Site is proprietary software and you may not use it except as expressly allowed under these T&C. You may not copy, reverse engineer, modify or otherwise deal with the software.

Where the Site contains links to other sites and resources provided by third parties, these links are provided for your information and convenience only. Accord does not have control over, and is not responsible for, the availability and content of those sites and resources. 

Changes to the Site, its contents and these T&C
Accord reserves the right to alter the Site, its contents and these T&C at any time, without prior notice. Any modification will take effect immediately. You agree to check these T&C regularly for modifications and additions.

Contents Use
You may download material displayed on the Site for non-commercial, personal use only, provided you also retain all copyright and other proprietary notices contained in the materials or as specified on the Site. Save as expressly permitted above, all use and reproduction of any material on this Site or any incorporation of the same into any other material, in whatever media or format, is strictly prohibited. You agree not to use the Site for any commercial or business purposes.

Slavery and Human Trafficking
Accord is absolutely committed to preventing slavery and human trafficking in its business activities and ensuring to the best of its ability that its supply chain is free from such activities. For further details, see Accord’s Modern Slavery Act Statement.

Personal Data
Accord may process the personal data supplied by you to Accord in accordance with Accord’s Cookies and Privacy Policy.

Liability and Indemnity
Although Accord endeavours to ensure the high quality and accuracy of the Site, Accord makes no warranty, express or implied, such as to the accuracy, completeness or adequacy, of the contents of the Site, which are provided "as is".

In no event will Accord, its affiliates, agents, suppliers or licensors be liable for any direct, special, incidental, exemplary, punitive, consequential or other loss or damage (including, without limitation, damages for loss of business profits, business interruption, loss of business information or other pecuniary loss) that may arise directly or indirectly from the use of (or failure to use) or reliance on the contents of this Site, even if Accord has been advised of the possibility that such damages may arise. For the avoidance of doubt:

  • Accord does not guarantee absence of virus or other elements that could damage or alter your computer system, electronic documents or files. Accord hereby notifies to all users that these may occur. Therefore, Accord does not accept liability for any damage that these elements could cause to you or to third parties.
  • Accord will not be liable if for any reason the Site is unavailable at any time or for any period. Accord accepts no responsibility for any errors, omissions, delays, or losses including loss of data during or as a result of the unavailability of the Site.

You agree to indemnify Accord, its affiliates, agents, suppliers or licensors immediately on demand, against all claims, liability, damages, costs and expenses, including reasonable legal fees, arising out of any breach of these T&C by you or your use of the Site.

Governing Law and Jurisdiction
These T&C will be governed by and construed in accordance with the laws of England. You (and Accord) submit irrevocably to the exclusive jurisdiction of the English Courts.

Other Terms
Notices to Accord must be given in writing, by letter, and sent to Sage House, 319 Pinner Road, North Harrow Middlesex, HA1 4HF, United Kingdom.

If any provision in these T&C is determined to be illegal, invalid or unenforceable, in whole or in part, then such provision or part of it shall, to the extent that it is illegal, invalid or unenforceable, be deemed not to form part of these T&C and the legality, validity and enforceability of the remainder of these T&C shall not be affected.

Save as expressly referred to therein, Accord makes no representations or warranties of any kind, express or implied, with respect to Site and its contents.

Headings in these T&C are for convenience only and have no legal meaning or effect, nor shall they be taken into account in interpreting these T&C.

Accord rights under the T&C may be waived only in writing and specifically.

The board of directors and management teams of Accord Healthcare Ltd’s (AHL) and its subsidiaries are fully committed to complying with competition law. The fundamental objective of competition law is to prevent distortion of competition in the market because competition ensures an efficient allocation of resources and, ultimately, enhances consumer welfare.

AHL is committed to bringing affordable life-saving medicines to patients and has thus adopted a robust compliance programme that includes a fair competition policy, employee training to aid understanding of competition law and how it applies to our business, and a whistleblowing line allowing our employees and business partners to safely (and anonymously) report any policy breaches.


Accord Healthcare Ltd Board of Directors
October 2019